Structure Therapeutics Inc. American Depositary Shares (GPCR · NASDAQ)
GPCR · MARKET VIEW
Market view · as of Jul 20, 2026
Revenue (TTM)
$0
0.0% YoY
EPS (latest q)
$-0.35
vs $-0.33 est · miss
52-wk position
41.6%
-48.3% vs 52w high · +7.7% 1mo
Price (last ~year)
Structure Therapeutics (GPCR) is a clinical-stage biopharmaceutical company developing oral therapeutics, currently carrying a $3.45 billion market capitalization. As of March 31, 2026, the firm maintains $316.2 million in cash against $5.8 million in total debt, while reporting $0 in TTM revenue and a $76.2 million net loss for the first quarter. Shares closed at $48.48, up 5.3% on the day, following recent conference presentations regarding its GLP-1 and amylin pipeline and reported insider share sales.
Valuation
- Market cap
- $3.45B
- P/B
- 2.382
- EV/EBITDA
- -13.46
- Beta
- -1.569
- Analyst target
- $104.59
Quality & returns
- Operating margin
- 0.0%
- Profit margin
- 0.0%
- ROE
- -15.0%
- ROA
- -11.6%
Price movement
- Last
- $48.48
- 1-month
- +7.7%
- 3-month
- +3.5%
- RSI (14)
- 47
- vs SMA200
- -4.8%
- 52-wk position
- 41.6% -48.3% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-03-31 | $0 | $-89.6M | $-76.2M | $-74.8M |
| 2025-12-31 | $0 | $24.0M | $33.0M | $33.6M |
| 2025-09-30 | $0 | $-73.8M | $-65.7M | $-65.3M |
| 2025-06-30 | $0 | $-70.5M | $-61.7M | $-61.2M |
Recent news
- Bullish (GPCR) as a Liquidity Pulse for Institutional Tactics · 2026-07-19
- Somewhat-Bullish Viking Therapeutics (NASDAQ:VKTX) stock maintains Phase 3 outlook despite 4.6% fall over the week · 2026-07-18
- Somewhat-Bearish Structure Therapeutics (NASDAQ: GPCR) CSO exercises options and sells ADS · 2026-07-16
- Neutral Form 4 Structure Therapeutics Inc ADR For: 15 July By Investing.com · 2026-07-15
- Bullish Structure Therapeutics (GPCR) Jefferies Global Healthcare Conference 2026 Summary · 2026-07-10
- Bullish Structure Therapeutics (GPCR) Morgan Stanley 23rd Annual Global Healthcare Conference summary · 2026-07-09
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)